18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Metastasis to the Thyroid Gland: A Critical Review

      review-article
      , MBChB, PhD 1 , , , MD, PhD 2 , , MBChB, MRCS-ENT 3 , , PhD, FRCPath 4 , 5 , , MD, PhD, FACS 6 , , MD, FACS 7 , , MD, FRCSEd ad hominem, FRCS (Eng, Ir) ad eundem, FRCSGlasg, FACS 8 , , MD 9 , , MD, FACS 10 , , MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP 11
      Annals of Surgical Oncology
      Springer International Publishing

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Metastasis to the thyroid gland from nonthyroid sites is an uncommon clinical presentation in surgical practice. The aim of this review was to assess its incidence management and outcomes.

          Methods

          A literature review was performed to identify reports of metastases to the thyroid gland. Both clinical and autopsy series were included.

          Results

          Metastases to the gland may be discovered at the time of diagnosis of the primary tumor, after preoperative investigation of a neck mass, or on histologic examination of a thyroidectomy specimen. The most common primary tumors in autopsy studies are from the lung. In clinical series, renal cell carcinoma is most common. For patients with widespread metastases in the setting of an aggressive malignancy, surgery is rarely indicated. However, when patients present with an isolated metastasis diagnosed during follow-up of indolent disease, surgery may achieve control of the central neck and even long-term cure. Other prognosticators include features of the primary tumor, time interval between initial diagnosis and metastasis, and extrathyroid extent of disease.

          Conclusions

          In patients with thyroid metastases, communication among clinicians treating the thyroid and the index primary tumor is essential. The setting is complex, and decisions must be made considering the features of the primary tumor, overall burden of metastases, and comorbidities. Careful balancing of these factors influences individualized approaches.

          Related collections

          Most cited references74

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer statistics for Hispanics/Latinos, 2012.

          Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010. In this article, the American Cancer Society updates a previous report on cancer statistics for Hispanics using incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. In 2012, an estimated 112,800 new cases of cancer will be diagnosed and 33,200 cancer deaths will occur among Hispanics. In 2009, the most recent year for which actual data are available, cancer surpassed heart disease as the leading cause of death among Hispanics. Among US Hispanics during the past 10 years of available data (2000-2009), cancer incidence rates declined by 1.7% per year among men and 0.3% per year among women, while cancer death rates declined by 2.3% per year in men and 1.4% per year in women. Hispanics have lower incidence and death rates than non-Hispanic whites for all cancers combined and for the 4 most common cancers (breast, prostate, lung and bronchus, and colorectum). However, Hispanics have higher incidence and mortality rates for cancers of the stomach, liver, uterine cervix, and gallbladder, reflecting greater exposure to cancer-causing infectious agents, lower rates of screening for cervical cancer, differences in lifestyle and dietary patterns, and possibly genetic factors. Strategies for reducing cancer risk among Hispanics include increasing utilization of screening and available vaccines, as well as implementing effective interventions to reduce obesity, alcohol consumption, and tobacco use. Copyright © 2012 American Cancer Society, Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Metastases in carcinoma; analysis of 1000 autopsied cases.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Metastases to the thyroid: a review of the literature from the last decade.

              Although clinically evident metastases of nonthyroid malignancies (NTMs) to the thyroid gland are uncommon, it is important to suspect them in patients who present with a new thyroid mass and a history, however far back, of prior malignancy. In fact, metastases from NTMs to the thyroid gland have been reported in 1.4%-3% of all patients who have surgery for suspected cancer in the thyroid gland. Here we review the literature over the last decade regarding this topic. Based on recent literature, the most common NTMs that metastasize to the thyroid gland are renal cell (48.1%), colorectal (10.4%), lung (8.3%), and breast carcinoma (7.8%), and sarcoma (4.0%). Metastases of NTMs to the thyroid are more common in women than men (female to male ratio=1.4 to 1) and in nodular thyroid glands (44.2%). The mean and median intervals between diagnosing NTMs and their metastases to thyroid gland are 69.9 and 53 months, respectively. In 20% of cases the diagnosis of the NTM and its metastases to the thyroid was synchronous. Recent reports indicate that there is a higher frequency of sarcoma metastasizing to the thyroid gland than reported in prior years. Fine-needle aspiration biopsy (FNAB) of thyroid masses is useful in diagnosis of thyroid metastases. However, this requires information about the NTM so that the proper antibodies can be used for immunohistochemical analysis; therefore it is of lesser utility if the NTM is occult. In patients with preexisting thyroid pathology the FNAB diagnosis can be more difficult due to more than one lesion being present. It is important to keep in mind that the thyroid gland can be a site of metastases for a variety of tumors when evaluating a thyroid nodule, especially in a patient with a prior history of malignancy. In patients with thyroid lesions and a history of malignant disease, regardless of time elapsed since the initial diagnosis of the primary neoplasm, disease recurrence or progression of malignancy must be considered until proven otherwise.
                Bookmark

                Author and article information

                Contributors
                iainjnixon@nhs.net
                Journal
                Ann Surg Oncol
                Ann. Surg. Oncol
                Annals of Surgical Oncology
                Springer International Publishing (Cham )
                1068-9265
                1534-4681
                21 November 2016
                21 November 2016
                2017
                : 24
                : 6
                : 1533-1539
                Affiliations
                [1 ]ISNI 0000 0001 0388 0742, GRID grid.39489.3f, ENT Department, , NHS Lothian, ; Lauriston Building, Lauriston Place, Edinburgh, UK
                [2 ]ISNI 0000 0001 2176 9028, GRID grid.411052.3, Department of Otolaryngology, , Hospital Universitario Central de Asturias, ; Oviedo, Spain
                [3 ]ENT Department, East and North Hertfordshire Trust, Stevenage, UK
                [4 ]ISNI 0000 0004 1936 8470, GRID grid.10025.36, Oral and Maxillofacial Pathology, School of Dentistry, , University of Liverpool, ; Liverpool, UK
                [5 ]Department of Cellular Pathology, Liverpool Clinical Laboratories, Liverpool, UK
                [6 ]ISNI 0000 0004 1936 7822, GRID grid.170205.1, Department of Surgery and MacLean Center for Clinical Ethics, , The University of Chicago Medicine, ; Chicago, IL USA
                [7 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Division of Surgical Oncology, Department of Surgery, , Mount Sinai School of Medicine, ; New York, NY USA
                [8 ]ISNI 0000 0001 2113 062X, GRID grid.5390.f, , University of Udine, ; Udine, Italy
                [9 ]ISNI 0000 0001 2171 9952, GRID grid.51462.34, Head and Neck Surgery, , Memorial Sloan Kettering Cancer Center, ; New York, NY USA
                [10 ]ISNI 0000 0001 2168 186X, GRID grid.134563.6, Department of Surgery, , University of Arizona College of Medicine—Phoenix, ; Phoenix, AZ USA
                [11 ]International Head and Neck Scientific Group, Padua, Italy
                Article
                5683
                10.1245/s10434-016-5683-4
                5413529
                27873099
                5911ec0e-b51e-4cb9-96d8-51da9b53df19
                © The Author(s) 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 25 August 2016
                Categories
                Endocrine Tumors
                Custom metadata
                © Society of Surgical Oncology 2017

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article